Update 1996: Blood collection and handling procedures for assessment of plasminogen activators and inhibitors (Leiden Fibrinolysis Workshop)

Fibrinolysis

Volumn 10, Issue SUPPL. 2, 1996, Pages 171-179

  Kluft, C ^a   Meijer, P ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

BLOOD; CONFERENCE PAPER; FIBRINOLYSIS; HUMAN; PRIORITY JOURNAL;

EID: 0029963427     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80080-4     Document Type: Conference Paper

References (33)

1. Kluft C, Verheijen JH. Leiden fibrinolysis working party: blood collection and handling procedures for assessment of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1). Fibrinolysis 1990; 4 suppl. 2: 155-161.
2. Thomson JM. Blood collection and preparation: pre-analytical variation. In: ECAT assay procedures. A manual of laboratory techniques. Jespersen J, Bertina RM, Haverkate F., eds. Kluwer Acad Publ. Dordrecht, The Netherlands. 1992 pp 13-20.
3. Huisveld I A, van den Burg PJM, Meijer P, van Vliet M, Hospers JEH, Mosterd WL, Bouma BN, Kluft C. Catheter unsuitable for the study of turn-over products of coagulation, fibrinolysis and platelet activation. Fibrinolysis 1992; 6, suppl. 3: 78-80.
4. Meijer P, Boon R, Jie AFH, Rosen S, Kluft C. Bioimmunoassay for tissue-type plasminogen activator (t-PA) in human plasma: evaluation of blood sampling and handling procedures and comparison with other t-PA activity methods. Fibrinolysis 1992; 6, suppl. 3: 97-99.
5. Van der Heide YT, Morrien W, van den Ende A. Evaluation of blood sampling for the measurement of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor activity (PAI-1). Fibrinolysis 1994; 8 suppl. 2: 152-153.
6. Eriksson E, Soderberg R, Risberg B. Influence of time, temperature and anticoagulant on the determination of t-PA activity. Fibrinolysis 1994; 8 suppl. 2: 150-151.
7. Sidelmann J. The influence of centrifugation load on platelet number and PAI-1 antigen concentration in human plasma. Fibrinolysis 1994; 8 Suppl 2: 148-149.
8. Meijer P, Kret R, Bloetjes PTM, Rosen S, Kluft C. New aspects of blood collection and handling procedures for the assessment of t-PA and PAI-1 variables after the introduction of acid blood collection. Fibrinolysis 1994; 8 suppl.2: 145-147.
9. Parekh RB, Dwek RA, Rudd PM, Thomas JR, Rademacher TW, Warren T, Wun TC, Herbert B, Reitz B, Palmier M, Ramabhadran T, Tiemeier DC. N-Glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line. Biochemistry 1989; 28: 7670-9.
10. Huisman LGM, van Griensven JMT, Kluft C. On the role of C1 -inhibitor as inhibitor of tissue-type plasminogen activator in human plasma. Thromb & Haemostas 1995; 73: 466-71.
11. Espana F, Vicente V, Estelles A, Vazques L, Hendl S, Sanchez-Cuenca J, Aznar J. Complex formation between protein C inhibitor and tissue plasminogen activator during thrombolytic therapy. Fibrinolysis 1993; 7: 308-315.
12. Sancho E, Declerck PJ, Price NC, Kelly SM, Booth NA. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms. Biochemistry. 1995; 34: 1064-9.
13. Philippe J, Dooijewaard G, Offner F, Turion P, Baele G, Leroux-Roels G. Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infection. Thromb & Haemostas 1992; 68: 19-23.
14. Gram J, Declerck PJ, Sidelmann J, Jespersen J, Kluft C. Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activity. Thromb & Haemostas 1993; 70: 852-857.
15. Jem C, Manhem K, Eriksson E, Tengborn L, Risberg B, Jem S. Hemostatic responses to mental stress during the menstrual cycle. Thromb & Haemostas 1991; 66: 614-618.
16. Snieder H, Huizink AC, Boomsma DI, van Doornen LJP. Influence of mental stress on fibrinogen, von Willebrand factor and tissue-type plasminogen activator antigen. Fibrinolysis 1996; 10 suppl. 2: 137-139.
17. Hafner G, Schinzel H, Ehrenthal W, Wagner C, Konheiser U, Zotz R, Lotz J, Blank R, Weileman LS, Prellwitz W. Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1+2 and thrombin-antithrombin HI complex. Aim Hematol 1993; 67: 121-125.
18. Meijer P, van der Ham F, Kluft C. The use of Stabilyte® plasma may cause changes in pH in the assay of some fibrinolysis analytes and might effect results. Fibrinolysis 1996; 10 suppl. 2: 155-157.
19. Huisman LGM, van Griensven JMT, Kluft C. Usefulness and limitations of Actilyse® for standardisation of tissue-type plasminogen activator (t-PA) assays in blood. Fibrinolysis 1996; 10 suppl. 2: 125-127.
20. Ranby M, Sundell IB, Nilsson TK. Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Tliromb & Haemostas 1989; 62: 917-922.
21. Meijer P, Follet DE, Wauters J, Kluft C. Specificity of antigen assays of plasminogen activator inhibitor in plasma: innotest PAI-1 immunoassay evaluated. Clin Chein 1994; 40: 110-115.
22. Nieuwenhuizen W, Laterveer R, Hoegee-de Nobel E, Bos R. A one-step enzyme immunoassay for total plasminogen activator inhibitor-1 antigen in human plasma. Blood Coagul Fibrinolys. 1995; 6: 268-272.
23. Nieuwenhuizen W, Laterveer R, Hoegee-de Nobel E. An enzyme immunoassay for the simultaneous determination of active type-1 plasminogen activator inhibitor (PAI-1), and t-PA/PAI-1 complexes. Blood Coagul Fibrinolysis 1995; 6: 520-526.
24. Griep EN, van der Zee MC, den Ottolander GJH. Determination of plasminogen activator inhibitor in human plasma and blood platelets and its clinical relevance. Fibrinolysis 1990; 4 suppl. 2: 141-144.
25. Binnema DJ, van Iersel JJL, Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Tliromb Res 1986; 43: 569-577.
26. Ǒzdemir O, Haznedaroglu ǏC, Sayinalp N, Ǒzcebe OǏ, Dundar S, Kirazli S. Blood collection in strong acidic citrate anticoagulant for the determination of urokinase-like plasminogen activator. Tliromb Res 1995; 80: 189-191.
27. Dooijewaard G, de Boer A, Turion PN, Cohen AF, Breimer DD, Kluft C. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma. Thromb Haemost 1991; 65: 82-86.
28. van den Burg PJM, Dooijewaard G, van Vliet M, Mosterd WL, Kluft C, Huisveld IA. Differences in u-PA and t-PA increase during acute exercise: relation with exercise parameters. Thromb Haemostas 1994; 71: 236-239.
29. Van Griensven JMT, Burggraaf KF, Gerloff J, Gunzler WA, Beier H, Kroon R, Huisman LGM, Schoemaker RC, Kluft C, Cohen AF. Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase, Clin Pharmacol Ther 1995; 57: 381-9.
30. Andreotti F, Kluft C. Circadian variation of fibrinolytic activity in blood. Chronobiol Intern. 1991; 8: 336-351.
31. Gilabert J, Estelles A, Aznar J, Espana F, Andres C, Santos T, Valles J. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia. Thromb & Haemostas 1990; 63: 361-366.
32. Declerck PJ, Moreau H, Jespersen J, Gram J, Kluft C. Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1). Tliromb Haemostas 1993; 70: 858-863.
33. Hendriks HFJ, Veenstra J, Velthuis-te Wierik EJM, Schaafsma G, Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br Med J 1994; 308: 1003-1006.